Avalo Therapeutics, Inc. (AVTX)
Pharmaceutical Preparations
Latest Price
$18.25
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
3.40
P/B Ratio
5.37
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 2.88M | $42.0M | 11.69% | +2.66M | 2026-03-31 |
| T. Rowe Price Investment Management, Inc. | 2.16M | $32.0M | 8.78% | -- | 2026-03-31 |
| Caligan Partners LP | 1.64M | $24.0M | 6.64% | +753.5K | 2026-03-31 |
| BVF INC/IL | 1.63M | $24.0M | 6.63% | +277.6K | 2026-03-31 |
| Avoro Capital Advisors LLC | 1.41M | $21.0M | 5.72% | -- | 2026-03-31 |
| Affinity Asset Advisors, LLC | 1.34M | $20.0M | 5.44% | +289.8K | 2026-03-31 |
| Logos Global Management LP | 1.30M | $19.0M | 5.28% | -- | 2026-03-31 |
| Nantahala Capital Management, LLC | 1.24M | $18.0M | 5.01% | -- | 2026-03-31 |
| UBS Group AG | 1.14M | $17.0M | 4.64% | +664.2K | 2026-03-31 |
| Caption Management, LLC | 1.09M | $16.0M | 4.41% | +784.1K | 2026-03-31 |